Raj Chopra
About Raj Chopra
Raj Chopra's Current Role
Raj Chopra holds the position of Head of Oncology and Venture Partner. In this capacity, he leverages his extensive experience in the field of oncology to guide research and development efforts. His role includes strategic decision-making, mentorship, and fostering partnerships within the oncology sector.
Raj Chopra's Education and Expertise
Raj Chopra earned a PhD in medicine, cell, and molecular biology from University College London. He is also a fellow of the Royal College of Physicians of London, the Royal College of Pathologists, and the Royal Society of Biology. This combination of advanced education and professional affiliations highlights his deep expertise in oncology and related fields.
Raj Chopra's Background in Oncology Leadership
Raj Chopra has held various leadership positions throughout his career. He directed the Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research in London. He also served as the corporate vice president of Translational and Early Drug Development at Celgene from 2009 to 2016. Additionally, he held roles in AstraZeneca's Oncology Therapeutics group and was the director of Hematological Oncology at Christie Hospital.
Raj Chopra's Early Career and Academic Contributions
Raj Chopra began his academic career as the director of Hematological Oncology at Christie Hospital. He was also a group leader at the Paterson Institute of Cancer Research in Manchester, UK. These early roles provided him with foundational experience and contributed significantly to his expertise in oncology research and treatment.
Raj Chopra's Entrepreneurial Ventures
Raj Chopra has been involved in several entrepreneurial ventures within the biotech sector. He was a non-executive director of Artios Pharma and co-founder of Monté Rosa Therapeutics. These roles underline his commitment to advancing cancer treatment through innovative biotech solutions.